Professor25/iStock via Getty Images
- DPV techniques (Nasdaq:DBVT) The stock rose 29% in after-market trading on Wednesday after the company said it had aligned with the Food and Drug Administration on an accelerated approval path for the Viaskin peanut allergy patch for children ages 1 to 3 years.
- the
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/475732628/image_475732628.jpg?io=getty-c-w750
Source link